Literature DB >> 2213906

Unexplained excess risk of bladder cancer in men.

P Hartge1, E B Harvey, W M Linehan, D T Silverman, J W Sullivan, R N Hoover, J F Fraumeni.   

Abstract

In nearly all populations studied, the risk of bladder cancer is two to four times as great in men as in women. We estimated what the gender-specific incidence rates would be in the absence of exposure to known carcinogenic factors. The data used were obtained from interviews with 2,806 white individuals with bladder cancer and 5,258 white controls in the National Bladder Cancer Study and from incidence data for 1978 from the National Cancer Institute Surveillance, Epidemiology, and End Results Program. The total age-adjusted incidence of bladder cancer was 27.5 cases per 100,000 person-years for men and 7.0 for women, yielding a ratio of 3.9. Even in the absence of exposure to cigarettes, occupational hazards, or urinary tract infection, the gender-related risk persisted; the incidence of bladder cancer was 11.0 in men and 4.1 in women, yielding a ratio of 2.7. Possible explanations for the excessive risk in men include environmental and dietary exposures not yet identified and innate sexual characteristics such as anatomic differences, urination habits, or hormonal factors.

Entities:  

Mesh:

Year:  1990        PMID: 2213906     DOI: 10.1093/jnci/82.20.1636

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  55 in total

Review 1.  The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

Authors:  Katarzyna Marcinkiewicz; Kymora B Scotland; Stephen A Boorjian; Emeli M Nilsson; Jenny Liao Persson; Per Anders Abrahamsson; Cinzia Allegrucci; Ieuan A Hughes; Lorraine J Gudas; Nigel P Mongan
Journal:  Int J Oncol       Date:  2011-09-28       Impact factor: 5.650

2.  Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.

Authors:  Carol A Davis-Dao; Katherine D Henderson; Jane Sullivan-Halley; Huiyan Ma; Dee West; Yong-Bing Xiang; Manuela Gago-Dominguez; Mariana C Stern; J Esteban Castelao; David V Conti; Malcolm C Pike; Leslie Bernstein; Victoria K Cortessis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

Review 3.  Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.

Authors:  Yuesheng Zhang
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

4.  Bladder cancer and reproductive factors among women in Spain.

Authors:  An-Tsun Huang; Manolis Kogevinas; Debra T Silverman; Nuria Malats; Nathaniel Rothman; Adonina Tardón; Consol Serra; Reina García-Closas; Alfredo Carrato; Kenneth P Cantor
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

5.  Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

Authors:  G J Wirth; A Haitel; M Moschini; F Soria; T Klatte; M R Hassler; K Bensalah; A Briganti; J A Karam; Y Lotan; V Margulis; J D Raman; M Remzi; N Rioux-Leclercq; B D Robinson; M Rouprêt; C G Wood; S F Shariat
Journal:  World J Urol       Date:  2016-10-11       Impact factor: 4.226

Review 6.  Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

Authors:  Andrea B Apolo; Vanessa Hoffman; Matthew G Kaag; David M Latini; Cheryl T Lee; Jonathan E Rosenberg; Margaret Knowles; Dan Theodorescu; Bogdan A Czerniak; Jason A Efstathiou; Matthew L Albert; Srikala S Sridhar; Vitaly Margulis; Surena F Matin; Matthew D Galsky; Donna Hansel; Ashish M Kamat; Thomas W Flaig; Angela B Smith; Edward Messing; Diane Zipursky Quale; Yair Lotan
Journal:  Urol Oncol       Date:  2014-07-25       Impact factor: 3.498

7.  The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.

Authors:  Zaixian Zhang; Qingquan Xu; Xiaobo Huang; Jia Yang; Yanhong Xu; Guixiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.

Authors:  Takashi Kawahara; Satoshi Inoue; Eiji Kashiwagi; Jinbo Chen; Hiroki Ide; Taichi Mizushima; Yi Li; Yichun Zheng; Hiroshi Miyamoto
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

9.  Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.

Authors:  Sarah E Daugherty; James V Lacey; Ruth M Pfeiffer; Yikyung Park; Robert N Hoover; Debra T Silverman
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

10.  Impact of age and gender on the clinicopathological characteristics of bladder cancer.

Authors:  Parag Gupta; Manoj Jain; Rakesh Kapoor; K Muruganandham; Aneesh Srivastava; Anil Mandhani
Journal:  Indian J Urol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.